How Faga was paid
$6.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Daniel FagaPresident and Chief Executive Officer and Director | $706,011 | $1,592,001 | $3,345,653 | $465,968 | $24,310 | $6,133,943 |
| Paul LizzulChief Medical Officer | $545,754 | $505,703 | $1,064,476 | $221,031 | $28,413 | $2,365,377 |
| Dennis MulroyChief Financial Officer | $510,070 | $397,444 | $836,687 | $224,431 | $39,295 | $2,007,927 |
What changed and why
- $6.1M$6,133,943 was CEO total compensation in 2025, compared with $13,630,292 in 2024.
- $3.3M$3,345,653 was the CEO’s 2025 option award grant-date fair value.
- $1.6M$1,592,001 was the CEO’s 2025 stock award grant-date fair value.
- $466K$465,968 was the CEO’s 2025 annual cash incentive payout.
- $3.9M$3,949,862 of the CEO’s 2024 stock awards related to PSUs tied to $50, $75, and $100 share prices.
- 2025 equity awards reflected accounting values that may differ from amounts executives ultimately receive.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.